DK175235B1 - Ny anvendelse af azatricycloderivater og farmaceutiske præparater med indhold deraf - Google Patents

Ny anvendelse af azatricycloderivater og farmaceutiske præparater med indhold deraf Download PDF

Info

Publication number
DK175235B1
DK175235B1 DK198806203A DK620388A DK175235B1 DK 175235 B1 DK175235 B1 DK 175235B1 DK 198806203 A DK198806203 A DK 198806203A DK 620388 A DK620388 A DK 620388A DK 175235 B1 DK175235 B1 DK 175235B1
Authority
DK
Denmark
Prior art keywords
dermatitis
topical
medicament
treatment
use according
Prior art date
Application number
DK198806203A
Other languages
Danish (da)
English (en)
Other versions
DK620388D0 (da
DK620388A (da
Inventor
Anton Stuetz
Peter Stuetz
Maximilian Grassberger
Josef Gottfried Meingassner
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25599336&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK175235(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from AT0295287A external-priority patent/AT400808B/de
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of DK620388D0 publication Critical patent/DK620388D0/da
Publication of DK620388A publication Critical patent/DK620388A/da
Application granted granted Critical
Publication of DK175235B1 publication Critical patent/DK175235B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK198806203A 1987-11-09 1988-11-07 Ny anvendelse af azatricycloderivater og farmaceutiske præparater med indhold deraf DK175235B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AT0295287A AT400808B (de) 1987-11-09 1987-11-09 Verwendung von tricyclischen verbindungen zur herstellung von topischen arzneimitteln
AT295287 1987-11-09
DE3742805 1987-12-17
DE3742805 1987-12-17

Publications (3)

Publication Number Publication Date
DK620388D0 DK620388D0 (da) 1988-11-07
DK620388A DK620388A (da) 1989-05-10
DK175235B1 true DK175235B1 (da) 2004-07-19

Family

ID=25599336

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198806203A DK175235B1 (da) 1987-11-09 1988-11-07 Ny anvendelse af azatricycloderivater og farmaceutiske præparater med indhold deraf

Country Status (13)

Country Link
US (1) US20050059694A1 (fr)
EP (2) EP0596541B1 (fr)
JP (1) JP2604834B2 (fr)
KR (1) KR0133916B1 (fr)
AU (1) AU619772B2 (fr)
CH (1) CH677448A5 (fr)
CY (1) CY1730A (fr)
DK (1) DK175235B1 (fr)
GB (1) GB2212061B (fr)
HK (1) HK8694A (fr)
NL (1) NL195077C (fr)
PH (1) PH26083A (fr)
SE (2) SE503236C2 (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
IE64214B1 (en) * 1989-06-06 1995-07-26 Fujisawa Pharmaceutical Co Macrolides for the treatment of reversible obstructive airways diseases
US5519049A (en) * 1989-06-06 1996-05-21 Fisons Plc Macrolides for the treatment of reversible obstructive airways diseases
ZA905202B (en) * 1989-07-05 1991-04-24 Fujisawa Pharmaceutical Co Aqueous liquid composition for external use
KR0159766B1 (ko) * 1989-10-16 1998-12-01 후지사와 토모키치로 양모제 조성물
US5215995A (en) * 1989-10-16 1993-06-01 Fujisawa Pharmaceutical Co., Ltd. Hair revitalizing agent
US5208228A (en) * 1989-11-13 1993-05-04 Merck & Co., Inc. Aminomacrolides and derivatives having immunosuppressive activity
GB8925797D0 (en) * 1989-11-15 1990-01-04 Fisons Plc Compositions
KR0177158B1 (ko) * 1990-03-01 1999-03-20 후지사와 도모기찌로 면역억제 활성을 갖는 트리사이클릭 화합물 함유 용액 제제
US5064835A (en) * 1990-03-01 1991-11-12 Merck & Co., Inc. Hydroxymacrolide derivatives having immunosuppressive activity
WO1991013899A1 (fr) * 1990-03-12 1991-09-19 Fujisawa Pharmaceutical Co., Ltd. Composes tricyclo
EP0455427A1 (fr) * 1990-04-30 1991-11-06 Merck & Co. Inc. Dérivés de déoxymacrolides à activité immunosuppressive
US5190950A (en) * 1990-06-25 1993-03-02 Merck & Co., Inc. Antagonists of immunosuppressive macrolides
US5342935A (en) * 1990-06-25 1994-08-30 Merck & Co., Inc. Antagonists of immunosuppressive macrolides
ES2099112T3 (es) * 1990-09-04 1997-05-16 Fujisawa Pharmaceutical Co Pomadas que contienen un compuesto triciclico.
GB2248184A (en) * 1990-09-28 1992-04-01 Fujisawa Pharmaceutical Co New use of macrolide compounds for active oxygen-mediated diseases
US5143918A (en) * 1990-10-11 1992-09-01 Merck & Co., Inc. Halomacrolides and derivatives having immunosuppressive activity
US5348966A (en) * 1990-10-24 1994-09-20 Fujisawa Pharmaceutical Co., Ltd. Method for treating pyoderma and Sezary's syndrome using FK 506 and related compounds
PH31204A (en) * 1990-11-02 1998-05-05 Fujisawa Pharmaceutical Co Pharmaceutical composition.
US5147877A (en) * 1991-04-18 1992-09-15 Merck & Co. Inc. Semi-synthetic immunosuppressive macrolides
US5250678A (en) 1991-05-13 1993-10-05 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
US5565560A (en) * 1991-05-13 1996-10-15 Merck & Co., Inc. O-Aryl,O-alkyl,O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
US5162334A (en) * 1991-05-13 1992-11-10 Merck & Co., Inc. Amino O-alkyl, O-alkenyl and O-alkynlmacrolides having immunosuppressive activity
US5189042A (en) * 1991-08-22 1993-02-23 Merck & Co. Inc. Fluoromacrolides having immunosuppressive activity
US5208241A (en) * 1991-09-09 1993-05-04 Merck & Co., Inc. N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
ZA926812B (en) 1991-09-09 1993-04-28 Merck & Co Inc O-heteroaryl,o-alkylheteroaryl,o-alkenylheteroaryl and o-alkynylheteroaryl macrolides having immunosupressive activity
US5286730A (en) * 1991-09-17 1994-02-15 American Home Products Corporation Method of treating immunoinflammatory disease
US5286731A (en) * 1991-09-17 1994-02-15 American Home Products Corporation Method of treating immunoinflammatory bowel disease
GB9218597D0 (en) * 1992-08-25 1992-10-14 Fisons Plc Novel method of treatment
MY110603A (en) * 1993-05-27 1998-08-29 Novartis Ag Tetrahydropyran derivatives
JPH06345646A (ja) * 1993-06-08 1994-12-20 Fujisawa Pharmaceut Co Ltd ローション剤
US5693648A (en) * 1994-09-30 1997-12-02 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynyl-macrolides having immunosuppressive activity
GB2308546B (en) 1994-10-26 1999-06-02 Novartis Ag Topical macrolide compositions
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
AU2004210201B2 (en) * 2003-02-06 2009-10-08 Cipla Limited Topical immunotherapy and compositions for use therein
US7186518B2 (en) * 2003-11-21 2007-03-06 Dade Behring Inc. Method and composition useful for determining FK 506
ES2478845T3 (es) 2008-10-08 2014-07-23 Takata Seiyaku Co., Ltd. Preparación de tacrolimus para aplicaciones externas
EP2308468A1 (fr) * 2009-10-08 2011-04-13 Novaliq GmbH Nouvelle composition pharmaceutique comportant un médicament contre l'immunosuppression macrolide
CN106074367A (zh) * 2016-07-20 2016-11-09 中山大学中山眼科中心 含fk506类化合物/fkbp蛋白二聚体的药物组合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139563A (en) * 1977-07-01 1979-02-13 Merrell Toraude Et Compagnie α-ACETYLENIC DERIVATIVES OF AMINES
EP0012866B1 (fr) * 1978-12-21 1983-01-19 Gruppo Lepetit S.P.A. 3H-Naphto (1,2-d) imidazoles, procédés pour leur préparation, composés pour utilisation comme des agents antiinflammatoires et antimicrobiens, et compositions pour cette utilisation les contenant
US4411893A (en) * 1981-08-14 1983-10-25 Minnesota Mining And Manufacturing Company Topical medicament preparations
US4556654A (en) * 1983-06-28 1985-12-03 Warner-Lambert Company Antimicrobial substituted anthra[1,9-cd]pyrazol-6(2H)-ones
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
CA1272953A (fr) * 1984-10-08 1990-08-21 Yuji Makino Compose pharmaceutique pour usage externe contenant de la vitasmine d.sub.3 de type acitf

Also Published As

Publication number Publication date
EP0315978A3 (en) 1990-06-13
EP0596541B1 (fr) 2000-03-15
SE9402558D0 (sv) 1994-07-22
DK620388D0 (da) 1988-11-07
AU619772B2 (en) 1992-02-06
US20050059694A1 (en) 2005-03-17
EP0596541A1 (fr) 1994-05-11
PH26083A (en) 1992-02-06
EP0315978B1 (fr) 1994-10-26
SE503236C2 (sv) 1996-04-22
DK620388A (da) 1989-05-10
KR890007736A (ko) 1989-07-05
GB2212061A (en) 1989-07-19
NL8802734A (nl) 1989-06-01
NL195077C (nl) 2003-07-23
JPH01157913A (ja) 1989-06-21
KR0133916B1 (ko) 1998-04-22
HK8694A (en) 1994-02-04
SE8804036L (sv) 1989-05-10
SE8804036D0 (sv) 1988-11-08
AU2490288A (en) 1989-05-11
GB2212061B (en) 1991-08-28
CH677448A5 (fr) 1991-05-31
SE519137C2 (sv) 2003-01-21
CY1730A (en) 1994-05-06
JP2604834B2 (ja) 1997-04-30
EP0315978A2 (fr) 1989-05-17
GB8826066D0 (en) 1988-12-14

Similar Documents

Publication Publication Date Title
DK175235B1 (da) Ny anvendelse af azatricycloderivater og farmaceutiske præparater med indhold deraf
Tamargo et al. Angiogenesis inhibition by minocycline
Priya et al. Healing potential of Datura alba on burn wounds in albino rats
Sacerdote et al. In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors
Wang et al. Curcumin promotes the spinal cord repair via inhibition of glial scar formation and inflammation
KR100299394B1 (ko) 면역염증성질환치료용약제학적조성물
Bajaj et al. Contact hypersensitivity to topical antibacterial agents
KR20050021464A (ko) 피부병의 국소 치료
US5665727A (en) Use of 11,28-dioxa-4-azatricyclo[22.3.1.04,9 ]octacos-18-ene derivatives and pharmaceutical compositions containing them
Marini et al. Modulation of IL-1 β gene expression by lipid peroxidation inhibition after kainic acid-induced rat brain injury
EP0535446B1 (fr) Compositions pharmaceutiques à usage topique contenant un agent de chelation, un tocophérol et un agent antimicrobien
Abe et al. Wound healing acceleration of a novel transforming growth factor-β inducer, SEK-1005
Zha et al. Serum factor (s) induced by restraint stress in mice and rats suppresses lymphocyte proliferation
KR20140055155A (ko) 자외선 등 피부 유해물질로부터 피부를 보호하여 피부 염증 또는 노화를 개선하는 물질 살리드로사이드
Shelton et al. Simulated abuse of tybamate in man: Failure to demonstrate withdrawal reactions
Fretland et al. Effect of the leukotriene B 4 receptor antagonist, SC-41930, on experimental allergic encephalomyelitis (EAE) in the guinea pig
Lee et al. Deferoxamine-induced cytotoxicity in human neuronal cell lines: protection by free radical scavengers
DE3838035C2 (de) Neue Verwendung von 11,28-dioxa-4-azatricyclo[22.3.1.O·4··,··9·]octacos-18-en-Derivaten
DE3844904C2 (de) Neue Verwendung von 11,28-Dioxa-4-azatricyclo-[22.3.1.0·4·,·9·]octacos-18-en-Derivaten
US20080004235A1 (en) Topical compositions comprising one or more of 4-thiouridine, isomaltitol and uridine
JPH09507845A (ja) 皮膚炎を治療するための２，３−ジアリル−１−ベンゾピラン
Metke Impact of inflammasome inhibition on the development of insulin resistance in the context of diet-induced obesity
AT407957B (de) Neue verwendung von 11,28-dioxa-4-azatricyclo- (22.3.1.04,9)octacos-18-en-derivaten und sie enthaltende pharmazeutische zubereitungen
Friedli et al. Effects of acute, low-dose UVB radiation on the induction of contact hypersensitivity to diphenylcyclopropenone in man
KR20140055970A (ko) 피부 염증 및 노화를 개선하기 위한 폴리갈락산 함유 조성물

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
PUP Patent expired